— Know what they know.
Not Investment Advice

PNT NASDAQ

POINT Biopharma Global Inc.
1W: +0.2% 1M: -8.4% 3M: +87.4% 1Y: +85.2% 3Y: -12.8%
$12.50
Last traded 2023-12-29 — delisted
NASDAQ · Healthcare · Biotechnology · $1.3B mcap · 87M float · 3.62% daily turnover

Balance Sheet Trends

Total Assets
$578M +119.7% ▲
3Y CAGR: +7793.2%
Total Liabilities
$91M +1035.6% ▲
3Y CAGR: +1963.4%
Shareholders Equity
$487M +90.8% ▲
Cash & Investments
$525M +119.9% ▲
Total Debt
$0 +0.0% ▲
Net Debt
-$286M -19.9% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022
— Assets —
Cash$0$11M$239M$286M
Short-Term Investments$0$0$0$239M
Cash & ST Investments$0$11M$239M$525M
Net Receivables$0$59K$73K$60K
Inventory$0$2M$0$0
Other Current Assets$1K$28K$105K$215K
Total Current Assets$1K$12M$244M$531M
Property, Plant & Equip.$0$10M$19M$31M
Goodwill & Intangibles$0$0$0$0
Long-Term Investments$0$0$0$16M
Other Non-Current Assets$0$0-$19M-$48M
Total Non-Current Assets$0$10M$19M$48M
Total Assets$1K$22M$263M$578M
— Liabilities —
Accounts Payable$0$4M$2M$8M
Short-Term Debt$0$0$0$0
Deferred Revenue$0$0$0$23M
Other Current Liabilities$10K$2M$6M$49M
Total Current Liabilities$10K$5M$8M$80M
Long-Term Debt$0$4M$0$0
Other Non-Current Liab.$0$0$0$1M
Total Non-Current Liabilities$0$4M$66K$12M
Total Liabilities$10K$9M$8M$91M
— Equity —
Common Stock$0$5K$9K$11K
Retained Earnings-$9K-$13M-$59M$39M
Accumulated OCI$0$0$0-$457K
Total Stockholders Equity-$9K$13M$255M$487M
Total Liabilities & Equity$0$22M$263M$578M
— Key Metrics —
Total Debt$0$4M$0$0
Net Debt$0-$7M-$239M-$286M
Total Investments$0$0$0$239M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms